Analysis of efficacy and factors that impact the response of secondary hyperparathyroidism to cinacalcet in haemodialysis patients Pilar Segura Torres, Borrego Utiel, Sánchez Perales, García Cortés, Biechy Baldán, Pérez Bañasco

Is cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis? María Dolores Arenas, Pablo Rebollo, Fernando Alvarez-Ude, Luis Prieto, Maria Teresa Gil, Tamara Malek, Analía Moledous, Carlos Núñez

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira, Catarina Meng, Manuel Augusto Gonçalves Amoedo, Maria Teresa de Sousa Costa Pinto Ferreira Mendes, Marco Alexandre Mateus Prazeres Marques, João Miguel Machado Dória Frazão, André Luiz Loureiro Weigert